Skip to content
PICO Portalanswers from OpenAlex

Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis.

PaperCitations, authors & open-access status

Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. is a paper indexed in PICO Portal from OpenAlex.

How many citations does Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. have?

PICO Portalcitation count

Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. has 2 citations in the OpenAlex counts PICO Portal stores.

When was Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. published?

PICO Portalyear

Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. has 2024 year in the PICO Portal index.

What is the open-access status of Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis.?

PICO Portaloa status

Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. has closed oa status in the PICO Portal index.

What is the DOI of Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis.?

PICO Portaldoi

The DOI for Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. is on the source record.

What is the PMID of Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis.?

PICO Portalpmid

The PMID for Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. is on the source record.

What is the OpenAlex record for Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis.?

PICO Portalopenalex

The OpenAlex for Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis. is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial